{"id":"W2979452863","doi":"10.1182/blood.v118.21.3761.3761","title":"Subcutaneous Omacetaxine in Chronic or Accelerated Chronic Myeloid Leukemia Resistant to Two or More Tyrosine-Kinase Inhibitors Including Imatinib,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Imatinib; Myeloid leukemia; Internal medicine; Dasatinib; Leukemia; Chronic myelogenous leukemia; Imatinib mesylate; Tyrosine-kinase inhibitor; Tyrosine kinase; Pharmacology; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005245831,0.0003483948,0.000671568,0.0003432941,0.0001667163,0.0003029356,0.0001562332,0.0003064633,0.001119967],"category_scores_gemma":[0.0004041592,0.0001236653,0.0003904817,0.0003990185,0.0003292368,0.0002411217,0.0001865083,0.0004108932,0.0001858409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002838057,"about_ca_system_score_gemma":0.0003317252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004845314,"about_ca_topic_score_gemma":0.0008317347,"domain_scores_codex":[0.9998087,0.0000598752,0.00001949343,0.00003907846,0.00002595135,0.00004676053],"domain_scores_gemma":[0.9996696,0.0001182922,0.00008738384,0.0000231009,0.000009952493,0.0000916889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2358827,0.01691692,0.3509159,0.0008454814,0.0008819727,0.008811568,0.0004552247,0.003301846,0.1770898,0.00058732,0.002140947,0.2021703],"study_design_scores_gemma":[0.02465814,0.3412754,0.5964002,0.00007412655,0.000617942,0.01217194,0.0003083813,0.00493072,0.01272999,0.000374955,0.00640063,0.00005758685],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988355,0.0005355123,0.00009078432,0.00002213186,0.000005367875,0.00006292664,0.0001041993,0.000003792697,0.0003397632],"genre_scores_gemma":[0.9989618,0.0003067209,0.000154133,0.00005679717,0.0000214525,0.00003798409,0.0002729821,0.000001333586,0.000186767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001119967,"threshold_uncertainty_score":0.003746688,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05843157775772467,"score_gpt":0.3155030366773857,"score_spread":0.257071458919661,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}